PROQR THRAPEUTICS N V's ticker is PRQR and the CUSIP is N71542109. A total of 69 filers reported holding PROQR THRAPEUTICS N V in Q3 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $63 | -100.0% | 17,256 | -90.8% | 0.00% | -100.0% |
Q3 2022 | $138,000 | +1625.0% | 187,034 | +1995.6% | 0.00% | – |
Q1 2022 | $8,000 | -68.0% | 8,925 | +144.9% | 0.00% | – |
Q2 2021 | $25,000 | – | 3,645 | +3545.0% | 0.00% | – |
Q4 2017 | $0 | – | 100 | 0.0% | 0.00% | – |
Q3 2017 | $0 | -100.0% | 100 | -98.4% | 0.00% | – |
Q4 2016 | $31,000 | -89.8% | 6,422 | -64.6% | 0.00% | -100.0% |
Q2 2015 | $303,000 | – | 18,152 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
M28 Capital Management LP | 1,910,600 | $2,483,780 | 2.85% |
Privium Fund Management B.V. | 5,344,446 | $6,947,780 | 2.07% |
DAFNA Capital Management LLC | 940,582 | $1,222,757 | 0.38% |
Monaco Asset Management SAM | 377,517 | $490,772 | 0.15% |
EcoR1 Capital, LLC | 2,980,016 | $3,874,021 | 0.13% |
Ikarian Capital, LLC | 472,625 | $614,412 | 0.07% |
FRANKLIN STREET ADVISORS INC /NC | 150,000 | $195 | 0.02% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 3,625,467 | $4,713,107 | 0.01% |
GSA CAPITAL PARTNERS LLP | 74,084 | $96 | 0.01% |
UBS OCONNOR LLC | 189,328 | $246,126 | 0.01% |